Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Clinical trial NCT01164228 · COMPLETED
Trial details
- NCT number
- NCT01164228
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-17
- Primary completion
- 2020-03-30
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.